[
  {
    "ts": null,
    "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=785ce8395338a6581d967654869a5174f17bac37e511a35b635519f6f3b752d1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749054600,
      "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "id": 135033534,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=785ce8395338a6581d967654869a5174f17bac37e511a35b635519f6f3b752d1"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10",
    "summary": "Presenter SpeechDavid Windley Hi. Good morning. I'm Dave Windley with Jefferies Healthcare Equity Research. Welcome to Jefferies 2025 New York Conference. Pleased to have you here. I appreciate the...",
    "url": "https://finnhub.io/api/news?id=f988a345caec9ed1565fa0c87274e7ecfed919f0405db4c76f76a50bdf025366",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749037819,
      "headline": "Transcript : Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10",
      "id": 135010701,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "Presenter SpeechDavid Windley Hi. Good morning. I'm Dave Windley with Jefferies Healthcare Equity Research. Welcome to Jefferies 2025 New York Conference. Pleased to have you here. I appreciate the...",
      "url": "https://finnhub.io/api/news?id=f988a345caec9ed1565fa0c87274e7ecfed919f0405db4c76f76a50bdf025366"
    }
  },
  {
    "ts": null,
    "headline": "Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers",
    "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Repligen (NASDAQ:RGEN) and the best and worst performers in the drug development inputs & services industry.",
    "url": "https://finnhub.io/api/news?id=6d6ae4182fb477fba1eab723bcf6ab4923ab74d412b11912d72ae3c68dafcf68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749007966,
      "headline": "Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers",
      "id": 135062363,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Repligen (NASDAQ:RGEN) and the best and worst performers in the drug development inputs & services industry.",
      "url": "https://finnhub.io/api/news?id=6d6ae4182fb477fba1eab723bcf6ab4923ab74d412b11912d72ae3c68dafcf68"
    }
  }
]